They progressively drew negative attention. "There isn't any question we have misplaced a considerable number of business for this reason substitution with the trade name with the generic name," Elliot Fisher, lawyer for Lemmon, who made the drug, informed Related Press in 1981.The general public thought that this new drug was less harmful than bar